Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1969
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients ; volume:39 ; number:11 ; day:15 ; month:9 ; year:2022 ; pages:841-849 ; date:11.2022
Drugs & aging ; 39, Heft 11 (15.9.2022), 841-849, 11.2022
- Creator
-
Novella-Navarro, Marta
Balsa, Alejandro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40266-022-00976-5
- URN
-
urn:nbn:de:101:1-2023011721014896453249
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Novella-Navarro, Marta
- Balsa, Alejandro
- SpringerLink (Online service)
Other Objects (12)
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Managing Difficult Conversation
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
New insights from a systematic review and meta-analysis on the treatment of difficult-to-treat rheumatoid arthritis
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis
Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
Difficult-to-treat HIV in Sweden: a cross-sectional study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Managing Difficult Conversation
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
New insights from a systematic review and meta-analysis on the treatment of difficult-to-treat rheumatoid arthritis
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis
Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
Difficult-to-treat HIV in Sweden: a cross-sectional study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Managing Difficult Conversation
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
New insights from a systematic review and meta-analysis on the treatment of difficult-to-treat rheumatoid arthritis
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis
Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
Difficult-to-treat HIV in Sweden: a cross-sectional study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis